OliX Pharmaceuticals
Suwon
About OliX Pharmaceuticals
OliX is a clinical stage biotechnology company, based on their own proprietary RNA interference (RNAi) technology regulating the expression of disease-causing genes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $37.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2020)
- Ticker: kosdaq:226950
- Website: olixpharma.com
- Phone: +82-031-779-8400
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/olix-pharmaceuticals-169661 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.